SyntheticMR AB engages in the development and marketing of software solutions for magnetic resonance imaging. The company is headquartered in Linkoping, Ostergotland and currently employs 37 full-time employees. The company went IPO on 2013-10-18. The firm provides SyMRI, which measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single MR scan. The SyMRI product is available in different packages. SyMRI IMAGE provides fast MRI workflows, allowing high patient throughput. SyMRI NEURO enables automatic segmentation of brain tissue, providing objective decision support. SyMRI Research Edition includes exportable SyMaps, parametric common contrast weighted images and maps of the brain, allowing the investigation to be taken even further. SyMRI is a registered trademark in Europe and in the USA.
SyntheticMR AB (publ) hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü yıllık ödenmektedir ve son temettü hariç tarihi Oct 2, 2020 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.00
Oct 2, 2020
Ödeme Sıklığı
Ödeme Oranı
Yıllık
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Oct 2, 2020
$0.1413
Oct 5, 2020
Oct 8, 2020
Apr 30, 2019
$0.1413
May 2, 2019
May 7, 2019
Dividend Grafikleri
SYNMF Kâr Payları
SYNMF Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
SyntheticMR AB (publ)'in şu anki temettü ödemesi ve yıllık temettüsü nedir?
SyntheticMR AB (publ)'in temettü ödeme oranı nedir?